Transforming growth factor‐β inhibits interleukin‐12‐induced production of interferon‐γ by natural killer cells: A role for transforming growth factor‐β in the regulation of T cell‐independent resistance to Toxoplasma gondii
- 1 April 1995
- journal article
- research article
- Published by Wiley in European Journal of Immunology
- Vol. 25 (4) , 994-1000
- https://doi.org/10.1002/eji.1830250420
Abstract
Severe-combined immune deficient (SCID) mice have been found to resist infection with the intracellular protozoan parasite Toxoplasma gondii via interleukin (IL)-12 stimulation of interferon (IFN)-γ production by natural killer (NK) cells. Previously, we demonstrated the presence of increased levels of transcripts for transforming growth factor-beta (TGF-β) in the brains and lungs of SCID mice infected with T. gondii, leading us to investigate the role of TGF-β in the mechanism of resistance to T. gondii in these mice. Stimulation of splenocytes from SCID mice with heat-killed T. gondii resulted in production of low levels of IFN-γ and a two to threefold increase in levels of TGF-β in the culture supernatants. Production of IFN-γ in these cultures was increased three to fourfold by addition of anti-TGF-β antibody. Stimulation of splenocytes from SCID mice with IL-12 in combination with either TNF-α or IL-1β resulted in production of high levels of IFN-γ. Addition of TGF-β to these cultures inhibited production of IFN-γ in a dose-dependent manner. Immunohistochemical studies revealed increased levels of TGF-β protein in the spleens of SCID mice 5 days after oral infection with the ME49 strain of T gondii, and brains of SCID mice at 18 days post-infection. However, no difference was detected in the levels of TGF-β transcripts in the spleens of uninfected mice or mice infected for 5 days. To test whether TGF-β could antagonize IL-12 mediated resistance to T. gondii in vivo, we administered TGF-β to SCID mice infected with T. gondii. This treatment resulted in earlier mortality of infected mice and significantly reduced the ability of exogenous IL-12 to delay time-to-death. Administration of anti-TGF-β to SCID mice, beginning 24 h prior to infection and every 2 days thereafter, delayed significantly time-to-death. Together, our data demonstrate that TGF-β antagonizes the ability of IL-12 to stimulate production of IFN-γ by splenocytes from SCID mice, and suggest a role for TGF-β in regulation of T cell-independent resistance to T. gondii.Keywords
This publication has 34 references indexed in Scilit:
- Natural killer cells participate in the early defense against Leishmania major infection in miceEuropean Journal of Immunology, 1993
- Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice.The Journal of Experimental Medicine, 1993
- Skin distribution and differential expression of transforming growth factor β1 and β2Journal of Dermatological Science, 1992
- Transforming growth factor-beta 1 (TGF-β1) expression and regulation in rat cortical astrocytesJournal of Neuroimmunology, 1992
- Natural Immunity: A T‐Cell‐Independent Pathway of Macrophage Activation, Defined in the scid MouseImmunological Reviews, 1991
- Astrocyte-derived TGF-beta 2 and NGF differentially regulate neural recognition molecule expression by cultured astrocytes.The Journal of cell biology, 1991
- Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta).The Journal of Experimental Medicine, 1991
- Evaluation of the Effect of Drugs on the Cyst Form of Toxoplasma gondiiThe Journal of Infectious Diseases, 1991
- Transforming growth factor beta is a potent inhibitor of interleukin 1 (IL-1) receptor expression: proposed mechanism of inhibition of IL-1 action.The Journal of Experimental Medicine, 1990
- Inhibition of cytokine production by cyclosporin A and transforming growth factor beta.The Journal of Experimental Medicine, 1987